اخبار بازار

آخرین اخبار مالی و اقتصادی، تحولات بازار، گزارش‌ها و تحلیل‌های بازارهای مالی را در PipVero دنبال کنید.

منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Earnings Estimates Rising for FormFactor (FORM): Will It Gain?

Earnings Estimates Rising for FormFactor (FORM): Will It Gain?

FormFactor (FORM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

نمادهای مرتبط 1
FORM FORM
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?

Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?

ADTN is expanding its AI networking portfolio, but execution issues and margin pressure may delay the payoff from growing AI infrastructure demand.

نمادهای مرتبط 1
ADTN ADTN
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven by higher product sales across its portfolio.

نمادهای مرتبط 1
RARE RARE
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.

نمادهای مرتبط 1
PLXS PLXS
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Market Watch خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli Lilly outmaneuvered it and took control of the diet-drug market.

نمادهای مرتبط 1
GLP GLP
منبع: Market Watch
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Seeking Alpha خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair (DINO) is rated Buy, with 50% upside to a $133 price target, driven by sustained tightness in global refined products markets. DINO's diversified model, including midstream and marketing, buffers refining margin volatility; the upcoming lubricants spinoff provides additional upside potential. Consensus forecasts underestimate the duration of elevated crack spreads, assuming rapid normalization, while my base case expects prolonged high margins due to persistent geopolitical disruptions.

نمادهای مرتبط 1
DINO DINO
منبع: Seeking Alpha
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Proactive Investors خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge Technologies (NASDAQ:SEDG) shares fell about 24% on Wednesday after the solar technology company issued a weaker-than-expected third quarter outlook, overshadowing better-than-expected second quarter results. The company guided for Q3 2026 revenue of $310 million to $340 million, with a midpoint of $325 million, below analyst expectations of roughly $368 million to $372 million.

نمادهای مرتبط 1
SEDG SEDG
منبع: Proactive Investors
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: 24/7 Wall Street خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
The Real Reason Berkshire Sold Every Amazon Share Has Nothing to Do With Amazon

The Real Reason Berkshire Sold Every Amazon Share Has Nothing to Do With Amazon

Berkshire Hathaway finished selling its Amazon (NASDAQ:AMZN | AMZN Price Prediction) position earlier this year in two clean sweeps.

نمادهای مرتبط 1
AMZN Amazon.com, Inc.
منبع: 24/7 Wall Street
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.

نمادهای مرتبط 1
AMGN AMGN
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Can MRVL's Communications Recovery Drive Broad-Based Growth?

Can MRVL's Communications Recovery Drive Broad-Based Growth?

Marvell Technology's MRVL communications and other business segment has been recovering as customer inventories normalize. In the first quarter of fiscal 2027, communications and other revenues increased 29% year over year to $585 million.

نمادهای مرتبط 1
MRVL MRVL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?

Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?

Boston Scientific's cheaper valuation offers upside, but weaker guidance, share losses, higher debt and delayed catalysts favor patience.

نمادهای مرتبط 1
BSX BSX
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Jacobs Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down

Jacobs Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down

J's Q3 revenues top estimates as record backlog and AI-related infrastructure demand support growth, even as the stock fell after results.

نمادهای مرتبط 1
J J
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Kratos Defense Q2 Earnings and Revenues Outpace Estimates

Kratos Defense Q2 Earnings and Revenues Outpace Estimates

KTOS delivers sharp Q2 earnings and revenue growth as government solutions, organic gains and strong bookings support performance.

نمادهای مرتبط 1
KTOS KTOS
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
LCID Q2 Earnings Miss on Inventory Charges, Revenues Beat Estimates

LCID Q2 Earnings Miss on Inventory Charges, Revenues Beat Estimates

Lucid's Q2 revenues jump 56.2% and beat estimates, but a $300 million inventory charge widens losses and keeps margins deeply negative.

نمادهای مرتبط 1
LCID LCID
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر